A detailed history of Sei Investments CO transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 48,361 shares of AXSM stock, worth $4.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
48,361
Previous 40,624 19.05%
Holding current value
$4.39 Million
Previous $3.27 Million 32.87%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$78.93 - $95.84 $610,681 - $741,514
7,737 Added 19.05%
48,361 $4.35 Million
Q2 2024

Aug 13, 2024

BUY
$65.72 - $80.5 $326,628 - $400,085
4,970 Added 13.94%
40,624 $3.27 Million
Q1 2024

May 07, 2024

BUY
$69.39 - $97.64 $187,144 - $263,335
2,697 Added 8.18%
35,654 $2.85 Million
Q4 2023

Feb 14, 2024

SELL
$57.42 - $83.61 $1.62 Million - $2.36 Million
-28,178 Reduced 46.09%
32,957 $2.62 Million
Q3 2023

Nov 14, 2023

SELL
$69.25 - $82.21 $8.53 Million - $10.1 Million
-123,132 Reduced 66.82%
61,135 $4.27 Million
Q2 2023

Aug 11, 2023

BUY
$58.41 - $90.35 $3.51 Million - $5.44 Million
60,158 Added 48.47%
184,267 $13.2 Million
Q1 2023

May 12, 2023

SELL
$58.39 - $75.0 $779,973 - $1 Million
-13,358 Reduced 9.72%
124,109 $7.66 Million
Q4 2022

Feb 10, 2023

SELL
$39.94 - $79.72 $452,200 - $902,589
-11,322 Reduced 7.61%
137,467 $10.6 Million
Q3 2022

Nov 14, 2022

SELL
$36.06 - $69.85 $497,519 - $963,720
-13,797 Reduced 8.49%
148,789 $6.64 Million
Q2 2022

Aug 15, 2022

BUY
$21.74 - $46.75 $352,688 - $758,425
16,223 Added 11.08%
162,586 $6.23 Million
Q1 2022

May 13, 2022

BUY
$23.7 - $41.39 $45,243 - $79,013
1,909 Added 1.32%
146,363 $6.06 Million
Q4 2021

Feb 14, 2022

SELL
$30.7 - $43.36 $41,076 - $58,015
-1,338 Reduced 0.92%
144,454 $5.46 Million
Q3 2021

Nov 12, 2021

SELL
$19.91 - $68.26 $7,725 - $26,484
-388 Reduced 0.27%
145,792 $4.81 Million
Q2 2021

Aug 06, 2021

BUY
$50.63 - $73.5 $101,766 - $147,735
2,010 Added 1.39%
146,180 $9.86 Million
Q1 2021

May 12, 2021

BUY
$55.91 - $81.44 $1.88 Million - $2.74 Million
33,649 Added 30.45%
144,170 $8.16 Million
Q4 2020

Feb 08, 2021

BUY
$66.31 - $86.52 $1.93 Million - $2.52 Million
29,098 Added 35.74%
110,521 $9 Million
Q3 2020

Nov 06, 2020

BUY
$68.34 - $85.84 $1.97 Million - $2.47 Million
28,796 Added 54.72%
81,423 $5.8 Million
Q2 2020

Aug 17, 2020

BUY
$49.87 - $98.69 $1.24 Million - $2.45 Million
24,845 Added 89.43%
52,627 $4.33 Million
Q2 2020

Aug 11, 2020

SELL
$49.87 - $98.69 $1.29 Million - $2.56 Million
-25,933 Reduced 48.28%
27,782 $2.77 Million
Q1 2020

May 14, 2020

BUY
$41.2 - $101.31 $882,998 - $2.17 Million
21,432 Added 66.39%
53,715 $3.16 Million
Q4 2019

Feb 06, 2020

BUY
$16.71 - $106.24 $159,329 - $1.01 Million
9,535 Added 41.92%
32,283 $3.34 Million
Q3 2019

Nov 12, 2019

SELL
$20.24 - $29.16 $99,378 - $143,175
-4,910 Reduced 17.75%
22,748 $460,000
Q2 2019

Aug 14, 2019

SELL
$13.46 - $25.75 $215,185 - $411,665
-15,987 Reduced 36.63%
27,658 $712,000
Q1 2019

May 15, 2019

BUY
$2.63 - $16.34 $114,786 - $713,159
43,645 New
43,645 $621,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.